GLO1 has been reported to be overexpressed in several human cancer cell lines including leukemia, melanoma, prostate cancer, and breast cancer cells [17–20] and has been implicated in cancer progression and drug resistance [21, 22]. This evidence concerns the gene GLO1 and breast cancer.